Resmed Inc. buy Mizuho
Start price
31.10.23
/
50%
€132.65
Target price
31.10.24
€150.86
Performance (%)
69.02%
End price
01.11.24
€224.20
Summary
This prediction ended on 01.11.24 with a price of €224.20. The BUY prediction by Mizuho for Resmed Inc. saw massive gains of 69.02%. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.82 are taken into consideration when calculating the performance. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -7.251% | -7.251% | -1.846% |
| iShares Core DAX® | -1,10 % | -6,08 % | 0,87 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 18,26 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 26,34 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 13,29 % |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Mizuho from $180.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten